Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 3343

BillFederalSenateIn Committee
A bill to amend the Federal Food, Drug, and Cosmetic Act to provide enhanced security for the medical supply chain.
About This Bill
Committee
Latest Action · February 27, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
116th (2019–2021)
Introduced
February 27, 2020
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Medical Supply Chain Security Act This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.